NPCE
Neuropace Inc
Price:  
9.52 
USD
Volume:  
232,551.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NPCE Fair Value

-139.72 %
Upside

What is the fair value of NPCE?

As of 2025-07-12, the Fair Value of Neuropace Inc (NPCE) is -3.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.52 USD, the upside of Neuropace Inc is -139.72%.

Is NPCE a good investment?

With the market price of 9.52 USD and our fair value calculation, Neuropace Inc (NPCE) is not a good investment. Investing in NPCE stocks now will result in a potential loss of 139.72%.

Note: valuation result may not be accurate due to the company's negative EPS.

9.52 USD
Stock Price
-3.78 USD
Fair Price
FAIR VALUE CALCULATION

NPCE Fair Value

Peter Lynch's formula is:

NPCE Fair Value
= Earnings Growth Rate x TTM EPS
NPCE Fair Value
= 5.00 x -0.76
NPCE Fair Value
= -3.78

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -24.28 -36.08 -47.08 -32.96 -27.14 -33.51
YoY growth 18.99% -48.60% -30.49% 30.00% 17.64% -2.49%

NPCE Fair Value - Key Data

Market Cap (mil) 312.26
P/E
Forward P/E
EPS -0.76
Avg earnings growth rate -2.49%
TTM earnings -24.80